Monitoring Dialysis Patients On Erythropoietin Therapy

At the start of treatment, patients receiving erythropoietin require fairly close monitoring every 2–4 weeks. As a minimum, the hemoglobin should be measured, there should be an assessment of iron status, and blood pressure should be checked.

Anemia In Dialysis Patients

Anemia is one of the major Hematological complications in Chronic Kidney Disease (CKD). Although anemia in CKD is multifactorial by far the main cause of anemia is due to inadequate production of hormone Erythropoietin by the diseased kidneys.